BR Biomedical Reports 2049-9434 2049-9442 D.A. Spandidos 10.3892/br.2015.433 BR-0-0-433 Articles Effects of high-fat diet on 1,2-dimethylhydrazine-induced aberrant crypt foci and colorectal tumours in rats QIGUANGYING 1 2 * TANGBO 3 * ZHOULIHUA 1 2 * JIKIHARAHIROSHI 2 KIWATAATSUMI 2 SAKAMOTOYUKI 2 TANGFANG 1 XIAOSHENGJUN 1 WANGZHENRAN 3 WUQIUHUI 1 LUHUILING 1 WUZHEN 1 ZENGSIEN 1 SHIMAMOTOFUMIO 2 Department of Pathology and Physiopathology, Guilin Medical University, Guilin, Guangxi 541004, P.R. China Department of Health Sciences, Faculty of Human Culture and Science, Prefectural University of Hiroshima, Hiroshima 734-8558, Japan Department of Hepatobiliary and Gastrointestinal Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, P.R. China Correspondence to: Professor Sien Zeng, Department of Pathology and Physiopathology, Guilin Medical University, 109 North 2nd Huan Cheng Road, Guilin, Guangxi 541004, P.R. China, E-mail: zse@glmc.edu.cn Professor Fumio Shimamoto, Department of Health Sciences, Faculty of Human Culture and Science, Prefectural University of Hiroshima, 1-1-71 Ujina-Higashi, Hiroshima 734-8558, Japan, E-mail: simamoto@pu-hiroshima.ac.jp

Contributed equally

 2015-05-01 2015-02-18 3 3 289 294 05012015 02022015 Copyright © 2015, Spandidos Publications 2015

Obesity is one of the leading causes of numerous types of cancer. The present study investigated the impact of a high-fat diet on 1,2-dimethylhydrazine (DMH)-induced colorectal cancer (CRC) in F344 rats. A total of 16 male F344 rats aged 4 weeks were randomly divided into two groups (8 rats/group). Rats in group A were fed a basal diet with a moderate fat (MF) content, while rats in group B were fed a high-fat diet. Upon reaching 5 weeks of age, the rats were injected subcutaneously with DMH (20 mg/kg body weight). DMH was administered once a week for 8 consecutive weeks. All the rats were sacrificed 34 weeks after the first DMH injection and dissected to obtain samples of colorectal tissues. The tissues were examined under a microscope for the presence of aberrant crypt foci (ACFs) and subjected to histopathological analysis. The results showed that at the end of the 34-week experiment, body weights and visceral fat levels were significantly higher in the high-fat diet group compared to the basal diet group. In addition, the incidences of colorectal ACF, adenoma and adenocarcinoma were markedly elevated in the high-fat diet group compared to the basal diet group. These results indicate that the consumption of a high-fat diet promotes the development and progression of CRC and the control of fat intake may prevent CRC.

 high-fat diet antitumour colorectal cancer F344 rats Introduction

Colorectal cancer (CRC) is the second and third most common malignancy in females and males, respectively, worldwide. Colon cancer is considered to be one of the leading causes of mortality in the world. There are extremely few therapeutic agents capable of effectively treating colon cancer (1). According to the GLOBOCAN database established by the World Health Organization (WHO), an estimated 12.7 million new cancer cases and 7.6 million cancer fatalities occurred in 2008 (2). The incidence of CRC is rising rapidly in numerous Asian countries and approaching the incidence in developed countries (3). Studies have shown that the incidence of malignant tumours has declined in males and females in the United States and one of the notable contributing factors is the decreased incidence of CRC. The results indicate that CRC occupies a predominant position among the malignancies in the United States (4). African-Americans have experienced an increased incidence of CRC compared to other U.S. populations. In addition, the prevalence of proximal CRC is higher among African-Americans and the average age for the onset of CRC is becoming younger (5). CRC is one of the common malignancies in China. The mortality rate of CRC in China is 4.54 per 100,000 population, which accounts for 4.9% of all cancer fatalities and ranks as the fifth highest among the malignant tumours. Notably, thus far the incidence and mortality rate of CRC continues to exhibit a tendency to increase. The five-year survival rates of CRC after curative resection remain near 50% (for rectal cancer) and 70% (for colon cancer). CRC is closely associated with the lifestyle of Western countries. Lifestyle and dietary patterns affect the risk of colon cancer. Among dietary factors, high intakes of red meat, fat and carbohydrates enhance the risk of developing CRC. By contrast, increased consumption of fruits, vegetables and fibres may reduce the incidence of CRC (6–8). The report released by the WHO and the Food and Agriculture Organization of the United Nations (FAO) in 2003 clearly stated that obesity is a risk factor for CRC (9). 1,2-Dimethylhydrazine (DMH) is a carcinogenic agent widely utilised to induce CRC in rats and other animal models. DMH is also commonly employed in chemistry-based cancer prevention studies (10). The present study mainly investigated the effects of a high-fat diet on DMH-induced CRC in F344 rats.

 Materials and methods <sec> <title>Animals

A total of 16 male 4-week-old F344 rats were purchased from Charles River Laboratories Japan, Inc. (Kanagawa, Japan). The animals were cared for in compliance with the principles and guidelines of Ethical Committee for Animal Care and Institutional Animal Ethical Committee, in accordance with the Japan National Law on Animal Care and Use. The Ethical Committee for Animal Care of the Prefectural University of Hiroshima (Hiroshima, Japan) approved the experiments undertaken. The rats were housed in a standard air-conditioned room at the Laboratory Animal Research Center of the Prefectural University of Hiroshima. The room provided a controlled ambient temperature of 23±2°C, a humidity of 50±10% and a daily light period of 12 h. The rats had free access to drinking water and were fed either a basal diet [moderate fat (MF)] or a high-fat diet (Oriental Yeast Co., Ltd., Tokyo, Japan). The main composition of the high-fat diet included lard, a fish meal, defatted soybean, vitamins and minerals (Table I). The contents of the three major types of nutrients in the high-fat and basal diets were compared and summarised in Table II. The contents of proteins, fats and carbohydrates were 60, 24.5 and 7.5 g, respectively, in 100 g of the high-fat diet and 23.6, 5.3 and 54.4 g, respectively, in the basal diet. The body weights of the rats were recorded once every two weeks. DMH was purchased from Tokyo Chemical Industry Co., Ltd., (Tokyo, Japan).

 Experimental protocol

The experimental design is shown in Fig. 1. The 16 male rats were randomly divided into two groups (8 rats/group) based on their diets: Group A, basal diet; group B, high-fat diet. DMH was dissolved in 0.9% sodium chloride and the pH value was adjusted to 6.5 with NaHCO3. Upon reaching 5 weeks of age, the experimental rats were injected subcutaneously with DMH (20 mg/kg body weight) once a week for 8 consecutive weeks. All the rats were sacrificed 34 weeks after the first DMH injection and dissected to obtain samples of colorectal tissues. The tissues were examined under a microscope for the presence of aberrant crypt foci (ACFs) and subjected to histopathological analysis.

 Analysis of ACFs and histological analysis

In rodents and humans, ACFs are believed to be the microscopic damage formed at the earliest stage of CRC development. ACFs may be the precancerous lesions that emerge prior to dysplasia (11). DMH-induced intestinal mucosal injury is a multi-step pathological process that involves the formation of ACFs, a gradual increase in the number of ACFs and eventually the development of CRC (12). The emergence of ACFs is closely associated with DMH. DMH is converted into azoxymethanol in vivo, which is further decomposed to form alkylated methyl diazonium. The product induces the methylation of DNA, RNA and proteins. DNA methylation results in chromosomal gene mutations and tumour cell formation. A study conducted by Tanaka (13) has shown that the DNA sequence of proto-oncogene K is mutated in ACFs, leading to the formation of adenomas. Subsequently, DNA repair errors and p53 gene mutation occur and adenomas develop further into adenocarcinomas.

After the animals were sacrificed, the entire colorectum was quickly removed and cut open along the longitudinal axis. The colorectal samples were rinsed clean with precooled 0.9% NaCl solution and laid onto filter paper with the mucosal side up. After 24 h of fixation at 4°C in 10% buffered formalin, the colorectal samples were stained with 0.5% methylene blue for 15–30 min, washed with distilled water, placed on glass slides and observed under an optical microscope using the 4 and 10X objectives. The number of ACFs was recorded. After the ACFs were recorded and calculated, the colorectal samples were fixed with 10% buffered formalin, embedded in paraffin, sectioned at a thickness of 4 µm, stained with hematoxylin and eosin and examined under an optical microscope (Olympus, Tokyo, Japan). The number of tumours was counted and tumour types and grades were investigated.

 Statistical analysis

The Statcel software package (KaleidaGraph version 4.1) was used for analysis. The Fisher's exact test and t-test (Statcel, the useful add in forms on Excel; 2nd edition) were used to compare data between the two groups. P<0.05 was considered to indicate a statistically significant difference.

 Results <sec> <title>Body weight and visceral fat content

Fig. 2A shows no significant differences in body weight between the two groups of rats within the first 14 weeks of the experiment. However, compared to the rats in the basal diet group, the rats in the high-fat diet group experienced significantly greater weight gains after 14 weeks. At the end of the 34-week experiment, body weights of the rats in the high-fat diet group were significantly higher compared to the rats in the basal diet group (418.6±14.9 vs. 381.9±20.9 g; P<0.05). For the purpose of the study, the amount of visceral fat was calculated as the sum of the amount of body fat deposited in the greater omentum and testicles. The amounts of visceral fat in the two groups of rats were determined and are shown in Fig. 2B. The amount of visceral fat was significantly increased in the high-fat diet group compared to that of the basal diet group (19.2±1.9 vs. 13.1±1.9 g; P<0.01). The average daily energy intake in each rat from the high-fat diet group was ~1.3-fold higher compared to that of the basal diet group and the average daily fat intake in each rat from the high-fat diet group increased ~8-fold compared to that of the basal diet group (data not shown).

 Colonic ACFs

The effect of the tested diets on the growth and development of DMH-induced ACFs in rats is shown in Fig. 3. All the rats treated with DMH showed a 100% incidence. The high-fat diet group showed a significantly higher average number of ACFs than that of the MF diet group.

 Colon tumours

The colorectal tissue sections were subjected to histopathological investigation and the results are summarised in Tables III and IV, and Fig. 4. Tables III and IV show that at the 34th week of the experiment, the incidence of colorectal adenomas and adenocarcinomas was significantly higher in the high-fat diet group compared to that of the basal diet group. A total of 119 adenomas were detected in the basal diet group, including 103 low-grade and 16 moderate-grade adenomas. The average number of adenomas developed in each rat was 14.8±8.5. By contrast, 175 adenomas were detected in the high-fat diet group, including 141 low-grade, 30 moderate-grade and 4 high-grade adenomas. The average number of adenomas observed in each rat was 21.9±7.2. The differences in the adenoma incidence between the two groups of rats were statistically significant (P<0.01). In addition, the numbers of highly, moderately and poorly differentiated adenocarcinomas found in the basal diet group were 4, 1 and 3, respectively. An average of 1.0±0.8 adenocarcinomas were developed in each rat. By contrast, the numbers of highly, moderately and poorly differentiated adenocarcinomas detected in the high-fat diet group were 16, 3 and 1, respectively. An average of 2.5±1.1 adenocarcinomas were developed in each rat. The differences in the adenocarcinoma incidence between the two groups of rats were also statistically significant (P<0.01).

 Discussion

Obesity is one of the leading causes of numerous types of cancer. The report released by the WHO and the FAO in 2003 clearly stated that obesity is a risk factor for CRC (9). Investigators in the U.S. have conducted studies on the potential link between obesity and cancer and found that in males and females, kidney cancer and cancers of the digestive system, such as oesophageal cancer, CRC, hepatobiliary and pancreatic cancers, are associated with obesity, as defined by high body mass index values (14). Relevant studies have shown that obese populations with high blood sugar levels have almost double the risk of developing obesity-related cancers, while obese populations with normal blood sugar levels only carry a 50% increased risk of developing cancers. In addition, metabolic dysfunction also increases the risk of cancer in obese individuals (15). In the present study, CRC was induced in rats using DMH. The rats were fed a high-fat diet and the effect of the high-fat diet-induced obesity on rat CRC was investigated. The results showed that after 14 weeks, the rats in the high-fat diet group experienced a significantly greater body weight gain compared to the rats in the basal diet group. At the end of the 34-week experiment, the average difference in body weights between the two groups of rats was ~40 g. The level of visceral fat was significantly higher in rats from the high-fat diet group compared to the rats from the basal diet group. In addition, the incidence of ACF, adenomas and adenocarcinomas was markedly elevated in the high-fat diet group compared to the basal diet group. The above results indicate that a high-fat diet promotes the development and progression of CRC in rats.

The mechanisms by which obesity induces CRC may be associated with insulin-resistant hyperinsulinaemia and insulin-like growth factors (IGFs) (14,16). To maintain normal blood sugar levels and carbohydrate metabolism, patients with insulin resistance require a large amount of insulin. A variety of conditions, such as obesity, inflammation and hyperlipidaemia, may result in the loss of normal insulin function. Obesity causes insulin resistance and hyperinsulinaemia. Shortly following the inhibition of insulin, the secretion and expression of IGF binding protein are altered, which increases the amount of free IGFs. Insulin and IGF-1 are growth factors that promote cell proliferation and inhibit apoptosis in cancer cells, resulting in tumour development and progression. Blood insulin levels measured in CRC patients and healthy individuals before breakfast and at 90 minutes after breakfast or lunch have shown that an increased IGF-1 level is associated with the incidence of CRC (17). In addition, the levels of C-peptide have been analysed in CRC patients and healthy individuals. The group with the highest C-peptide value exhibits a 3.2-fold increase in CRC risk compared to the group with the lowest C-peptide value. Higher C-peptide values indicate a greater risk of CRC (17,18).

In addition to insulin resistance, high-fat diet-induced bile acid secretion also promotes CRC development. Increased animal fat intake enhances the levels of secreted bile acids and cholesterol in bile. Bile acids and cholesterol are converted to secondary bile acids and steroids by bacteria in the colon, which are further metabolised by colonic bacteria into carcinogens (19). Animal experiments have shown that a high-fat diet increases bile acid secretion. Bile acids exhibit no direct carcinogenic effects; however, they increase the rate of cancer induction by carcinogens through accelerating cell turnover (20). This study showed that the consumption of a high-fat diet significantly increased the incidence of colorectal adenomas and adenocarcinomas, indicating that the cancer-promoting effect of a high-fat diet is associated with the increased secretion of bile acids. In addition, bile acids induce the expression of cyclooxygenase-2 (Cox-2) in CRC cells (21). Cox-2 is rarely expressed in the majority of normal tissues but is highly expressed in cancer cells. Cox-2 inhibits apoptosis in cancer cells and promotes angiogenesis (21–23). In addition, secondary bile (docosahexaenoic acid) triggers the production of the receptor of urokinase-type activating factor and is associated with the increased invasiveness of CRC cells (24).

Obesity is a strong risk factor for CRC. Adiponectin (APN) is a lipid factor secreted by adipose tissue that exhibits an immune-modulatory, anticancer effect in carbohydrate and lipid metabolism in CRC. A number of studies have shown that obesity is associated with APN and the incidence of CRC (25–29). Wei et al (30) found that the level of APN was reduced in obese individuals. APN deficiency induces chronic inflammation of the large intestine, which may further develop into CRC and increase the risk of developing cancer. Saxena et al (31) have investigated DMH-induced CRC under the condition of APN deficiency and identified that experimental animals deficient in APN clearly exhibit the clinical symptoms of carcinogenesis.

The consumption of a high-fat diet induces insulin resistance and increases bile secretion. The products of lipid metabolism exhibit mutagenic effects on DNA and RNA. In addition, the APN level is reduced in individuals with a high body fat level. Therefore, a high-fat diet promotes the development of CRC. Exercise may have a preventive effect against CRC. It is also necessary to maintain a nutritionally balanced diet and avoid excess fat intake. The present study also showed that the consumption of a high-fat diet promoted the development and progression of CRC. Therefore, controlling fat intake may prevent CRC.

 Acknowledgements

The present study was supported in part by the Important Research Grant from the Prefectural University of Hiroshima, Hiroshima Tsuchiya General Hospital. The authors thank them for their technical and materials assistance.

 References MisraSGhatakSVyasAIsothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancerMed Chem Res2338363851201410.1007/s00044-014-0958-425013352 FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer12728932917201010.1002/ijc.2551621351269 ChungSJKimYSYangSYSongJHParkMJKimJSJungHCSongISPrevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40–49 years undergoing screening colonoscopyJ Gastroenterol Hepatol25519525201010.1111/j.1440-1746.2009.06147.x20370730 JemalASiegelRXuJWardECancer statistics 2010CA Cancer J Clin60277300201010.3322/caac.2007320610543 XicolaRGagnonMClarkJRExcess of proximal microsatellite-stable colorectal cancer in African Americans from a multiethnic studyClin Cancer Res2049624970201410.1158/1078-0432.CCR-14-035325013126 ChanATGiovannucciELPrimary prevention of colorectal cancerGastroenterology13820292043201010.1053/j.gastro.2010.01.05720420944 WillettWCStampferMJColditzGARosnerBASpeizerFERelation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among womenN Engl J Med32316641672199010.1056/NEJM1990121332324042172820 MacdonaldRSWagnerKInfluence of dietary phytochemicals and microbiota on colon cancer riskJ Agric Food Chem6067286735201210.1021/jf204230r22632581 AmineEKBabaNHBelhadjMDiet, nutrition and the prevention of choronic diseasesWorld Health Organ Tech Rep Ser91611492003 BaskarAAIgnacimuthuSPaulrajGMAl NumairKSChemopreventive potential of beta-Sitosterol in experimental colon cancer model - an in vitro and in vivo studyBMC Complement Altern Med1024201010.1186/1472-6882-10-2420525330 InamineMSuzuiMMoriokaTKinjoTKaneshiroTSugishitaTOkadaTYoshimiNInhibitory effect of dietary monoglucosylceramide 1-O-beta-glucosyl-N-2′-hydroxyarachidoyl-4,8-sphingadienine on two different categories of colon preneoplastic lesions induced by 1,2-dimethylhydrazine in F344 ratsCancer Sci96876881200510.1111/j.1349-7006.2005.00127.x16367907 RodriguesMASilvaLASalvadoriDMDe CamargoJLMontenegroMRAberrant crypt foci and colon cancer: Comparison between a short- and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar ratsBraz J Med Biol Res35351355200210.1590/S0100-879X200200030001011887213 TanakaTDevelopment of an inlammation-associated colorectal cancer model and its application for research on carcinogenesis and chemopreventionInt J Inflamm2012116201210.1155/2012/658786 FrezzaEEWachtelMSChiriva-InternatiMInfluence of obesity on the risk of developing colon cancerGut55285291200610.1136/gut.2005.07316316239255 MooreLLChadidSSingerMRKregerBEDenisGVMetabolic health reduces risk of obesity-related cancer in framingham study adultsCancer Epidemiol Biomarkers Prev2320572065201410.1158/1055-9965.EPI-14-024025012997 GiovannucciEInsulin, insulin-like growth factors and colon cancer: A review of the evidenceJ Nutr131(Suppl 11)3109S3120S200111694656 OtaniTIwasakiMSasazukiSPlasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: The Japan public health center-based prospective studyInt J Cancer12020072012200710.1002/ijc.2255617266031 PowellAALaRueJMBattaAKMartinezJDBile acid hydrophobicity is correlated with induction of apoptosis and/or growth arrest in HCT116 cellsBiochem J356481486200110.1042/0264-6021:356048111368775 HillMJAriesVCFaecal steroid composition and its relationship to cancer of the large bowelJ Pathol104129139197110.1002/path.17110402075111052 RyserHJPChemical carcinogenesisN Engl J Med285721734197110.1056/NEJM1971092328513054942982 OshioHAbeTOnogawaTPeroxisome proliferator-activated receptor alpha activates cyclooxygenase-2 gene transcription through bile acid transport in human colorectal cancer cell linesJ Gastroenterol43538549200810.1007/s00535-008-2188-318648741 WangDWangHShiQKatkuriSWalhiWDesvergneBDasSKDeySKDuBoisRNProstaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor deltaCancer Cell6285295200410.1016/j.ccr.2004.08.01115380519 TsujiiMKawanoSTsujiSCyclooxygenase regulates angiogenesis induced by colon cancer cellsCell93705716199810.1016/S0092-8674(00)81433-69630216 BaekMKParkJSParkJHKimMHKimHDBaeWKChungIJShinBAJungYDLithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cellsCancer Lett290123128201010.1016/j.canlet.2009.08.03019782465 LarssonSCWolkAObesity and colon and rectal cancer risk: A meta-analysis of prospective studiesAm J Clin Nutr86556565200717823417 GunterMJLeitzmannMFObesity and colorectal cancer: Epidemiology, mechanisms and candidate genesJ Nutr Biochem17145156200610.1016/j.jnutbio.2005.06.01116426829 CalleEEKaaksROverweight, obesity and cancer: Epidemiological evidence and proposed mechanismsNat Rev Cancer4579591200410.1038/nrc140815286738 BirminghamJMBusikJVHansen-SmithFMFentonJINovel mechanism for obesity-induced colon cancer progressionCarcinogenesis30690697200910.1093/carcin/bgp04119221001 BianchiniFKaaksRVainioHOverweight, obesity, and cancer riskLancet Oncol3565574200210.1016/S1470-2045(02)00849-512217794 WeiEKGiovannucciEFuchsCSWillettWCMantzorosCSLow plasma adiponectin levels and risk of colorectal cancer in men: A prospective studyJ Natl Cancer Inst9716881694200510.1093/jnci/dji37616288122 SaxenaAChumanevichAFletcherELarsenBLattweinKKaurKFayadRAdiponectin deficiency: Role in chronic inflammation induced colon cancerBiochim Biophys Acta1822527536201210.1016/j.bbadis.2011.12.00622198319

Experiment protocol. MF, moderate fat; DMH, 1,2-dimethylhydrazine.

Body weights and visceral fat content of the different groups of F344 rats throughout the experiment. (A) The body weights of the different groups of F344 rats. (B) Visceral image of the different groups of rats; (a) moderate fat (MF) and (b) high-fat diet groups. (C) Visceral fat content of the different groups of F344 rats, **P<0.01.

Aberrant crypt foci (ACFs) expression in the colon of rats treated with 1,2-dimethylhydrazine (DMH) and stained with 0.5% methylene blue at week 34. (A) ACF expression in the colon of rats treated with DMH and stained with 0.5% methylene blue. (a) ACF expression in the colon from a rat in the modified fat (MF) group. Arrows point to the four and five crypts in the colon. (b) ACF expression in the colon of a rat in the high-fat diet group. Arrows point to the multiple crypts in the colon. (B) Number of ACFs in the colon, **P<0.01.

1,2-Dimethylhydrazine-induced colorectal tumours in rats. (A) Hyperplasia. (B) Adenoma with mild atypia. (C) Adenoma with moderate atypia. (D) Well-differentiated tubular adenocarcinomas. (E) Moderately differentiated adenocarcinomas. (F) Poorly differentiated adenocarcinomas. Haematoxylin and eosin stains (magnification, x200).

Contents of the high-fat diet.

Nutrient composition of the high-fat diet %
Lard 58
Fish meal 30
Defatted soybean 10
Vitamins, minerals and other components 2

Contents of the three major types of nutrients in the basal and high-fat diets (100 g).

Nutrients Basal diet High-fat diet
Protein, g 23.6 24.5
Fat, g 5.3 60
Carbohydrate, g 54.4 7.5
Total energy, kcal 360 640

Number of colon adenomas.

No. of colon adenomas
Group Mild-grade dysplasia Moderate-grade dysplasia Severe-grade dysplasia Total No. of colon adenomas per rat
A 103 16 0 118 14.8±8.54a
B 141 30 4 175 21.9±7.19

P<0.01.

Number of colon adenocarcinomas per rat.

No. of colon adenocarcinomas
Group Well-differentiated adenocarcinomas Moderately differentiated adenocarcinomas Poorly differentiated adenocarcinomas Total No. of colon adenocarcinomas per rat
A 4 1 3 8 1.0±0.83a
B 16 3 1 20 2.5±1.07

P<0.01.